Advanced glycation end products increase carbohydrate responsive element binding protein expression and promote cancer cell proliferation

Molecular and Cellular Endocrinology

Volumn 395, Issue 1-2, 2014, Pages 69-78

  Chen, Hanbei ^a   Wu, Lifang ^a   Li, Yakui ^a   Meng, Jian ^a   Lin, Ning ^a   Yang, Dianqiang ^a,b   Zhu, Yemin ^a   Li, Xiaoyong ^a   Li, Minle ^a   Xu, Ye ^c   Wu, Yuchen ^c   Tong, Xuemei ^a   Su, Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Advanced glycation end products; Cancer; Carbohydrate responsive element binding protein; Diabetes mellitus; Proliferation; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE; MLXIPL PROTEIN, HUMAN; MOK PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EMBRYO; GLYCOLYSIS; HCT116 CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CANCER; METABOLIC DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; UPREGULATION; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; PATHOLOGY;

ANTIGENS, NEOPLASM; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION END PRODUCTS, ADVANCED; HEP G2 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; NEOPLASMS;

EID: 84906346128     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.07.021     Document Type: Article

References (45)

1. Abe R., Shimizu T., Sugawara H., Watanabe H., Nakamura H., Choei H., et al. Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions. J. Invest. Dermatol 2004, 122(2):461-467.
2. Barone B.B., Yeh H.C., Snyder C.F., Peairs K.S., Stein K.B., Derr R.L., et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008, 300(23):2754-2764.
3. Berrou J., Tostivint I., Verrecchia F., Berthier C., Boulanger E., Mauviel A., et al. Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells. Int. J. Mol. Med 2009, 23(4):513-520.
4. Bidasee K.R., Zhang Y., Shao C.H., Wang M., Patel K.P., Dincer U.D., et al. Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase. Diabetes 2004, 53(2):463-473.
5. Bierhaus A., Nawroth P.P. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 2009, 52(11):2251-2263.
6. Billin A.N., Ayer D.E. The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism. Curr. Top. Microbiol. Immunol 2006, 302:255-278.
7. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. NEJM 1988, 318(20):1315-1321.
8. Cho H.J., Son S.M., Jin S.M., Hong H.S., Shin D.H., Kim S.J., et al. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model. FASEB J 2009, 23(8):2639-2649.
9. Collier J.J., Zhang P., Pedersen K.B., Burke S.J., Haycock J.W., Scott D.K. c-Myc and ChREBP regulate glucose-mediated expression of the L-type pyruvate kinase gene in INS-1-derived 832/13 cells. Am. J. Physiol. Endocrinol. Metab 2007, 293(1):E48-E56.
10. Coughlin S.S., Calle E.E., Teras L.R., Petrelli J., Thun M.J. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am. J. Epidemiol 2004, 159(12):1160-1167.
11. da Silva Xavier G., Rutter G.A., Diraison F., Andreolas C., Leclerc I. ChREBP binding to fatty acid synthase and L-type pyruvate kinase genes is stimulated by glucose in pancreatic beta-cells. J. Lipid Res 2006, 47(11):2482-2491.
12. Davies M.N., O'Callaghan B.L., Towle H.C. Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity. J. Biol. Chem 2008, 283(35):24029-24038.
13. Dentin R., Pégorier J.P., Benhamed F., Foufelle F., Ferré P., Fauveau V., et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J. Biol. Chem 2004, 279(19):20314-20326.
14. Gebhardt C., Riehl A., Durchdewald M., Németh J., Fürstenberger G., Müller-Decker K., et al. RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med 2008, 205(2):275-285.
15. Giovannucci E., Harlan D.M., Archer M.C., Bergenstal R.M., Gapstur S.M., Habel L.A., et al. Diabetes and cancer: a consensus report. Diabetes Care 2010, 33(7):1674-1685.
16. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
17. Hardie D.G. AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 2013, 62(7):2164-2172.
18. He Z., Jiang T., Wang Z., Levi M., Li J. Modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue. Am. J. Physiol. Endocrinol. Metab 2004, 287(3):E424-E430.
19. Huang J.S., Guh J.Y., Chen H.C., Hung W.C., Lai Y.H., Chuang L.Y. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J. Cell. Biochem 2001, 81(1):102-113.
20. Iizuka K., Bruick R.K., Liang G., Horton J.D., Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. PNAS 2004, 101(19):7281-7286.
21. Ishibashi Y., Matsui T., Takeuchi M., Yamagishi S. Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase. Horm. Metab. Res 2013, 45(5):387-390.
22. Kabashima T., Kawaguchi T., Wadzinski B.E., Uyeda K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(9):5107-5112.
23. Kawaguchi T., Osatomi K., Yamashita H., Kabashima T., Uyeda K. Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J. Biol. Chem 2002, 277(6):3829-3835.
24. Kent M.J., Light N.D., Bailey A.J. Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro. Biochem. J. 1985, 225(3):745-752.
25. Kim J.Y., Park H.K., Yoon J.S., Kim S.J., Kim E.S., Ahn K.S., et al. Advanced glycation end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways. Int. J. Oncol 2008, 33(3):493-501.
26. Lander H.M., Tauras J.M., Ogiste J.S., Hori O., Moss R.A., Schmidt A.M. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogenactivated protein kinase pathway regulated by oxidant stress. J. Biol. Chem 1997, 272(28):17810-17814.
27. Liang H., Zhong Y., Zhou S., Peng L. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo. Cancer Lett 2011, 313(1):91-98.
28. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem 1992, 267(21):14998-15004.
29. Ott C., Jacobs K., Haucke E., Navarrete Santos A., Grune T., Simm A. Role of advanced glycation end products in cellular signaling. Redox Biol 2014, 2:411-429.
30. Pusterla T., Nèmeth J., Stein I., Wiechert L., Knigin D., Marhenke S., et al. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice. Hepatology 2013, 58(1):363-373.
31. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest 2001, 108(7):949-955.
32. Sciacca L., Vigneri R., Tumminia A., Frasca F., Squatrito S., Frittitta L., et al. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients. Nutr. Metab. Cardiovasc. Dis 2013, 23(9):808-815.
33. Shikata K., Ninomiya T., Kiyohara Y. Diabetes mellitus and cancer risk: review of the epidemiological evidence. Cancer Sci 2013, 104(1):9-14.
34. Sorci G., Riuzzi F., Giambanco I., Donato R. RAGE in tissue homeostasis, repair and regeneration. Biochim. Biophys. Acta 2013, 1833(1):101-109.
35. Takeuchi M., Yanase Y., Matsuura N., Yamagishi Si S., Kameda Y., Bucala R., et al. Immunological detection of a novel advanced glycation end-product. Mol. Med 2001, 7(11):783-791.
36. Thornalley P.J. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell. Mol. Biol. (Noisy-Le-Grand) 1998, 44(7):1013-1023.
37. Thorpe S.R., Baynes J.W. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 2003, 25(3-4):275-281.
38. Tong X., Zhao F., Mancuso A., Gruber J.J., Thompson C.B. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proceedings of the National Academy of Sciences USA 2009, 106(51):21660-21665.
39. Wang H., Wollheim C.B. ChREBP rather than USF2 regulates glucose stimulation of endogenous L-pyruvate kinase expression in insulin-secreting cells. J. Biol. Chem 2002, 277(36):32746-32752.
40. Wang L., Duke L., Zhang P.S., Arlinghaus R.B., Symmans W.F., Sahin A., et al. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res 2003, 63(15):4724-4730.
41. Wu C.H., Huang C.M., Lin C.H., Ho Y.S., Chen C.M., Lee H.M. Advanced glycosylation end products induce NF-kappaB dependent iNOS expression in RAW 264.7 cells. Mol. Cell. Endocrinol 2002, 194(1-2):9-17.
42. Xie J., Méndez J.D., Méndez-Valenzuela V., Aguilar-Hernández M.M. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell. Signal 2013, 25(11):2185-2197.
43. Yamagishi S., Yonekura H., Yamamoto Y., Katsuno K., Sato F., Mita I., et al. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J. Biol. Chem 1997, 272(13):8723-8730.
44. Yamashita H., Takenoshita M., Sakurai M., Bruick R.K., Henzel W.J., Shillinglaw W., et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(16):9116-9121.
45. You J., Peng W., Lin X., Huang Q.L., Lin J.Y. PLC/CAMK IV-NF-kappaB involved in the receptor for advanced glycation end products mediated signaling pathway in human endothelial cells. Mol. Cell. Endocrinol 2010, 320(1-2):111-117.